Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Redha I. Azhar"'
Autor:
Sahar J. Alothman, Keunsoo Kang, Xuefeng Liu, Ewa Krawczyk, Redha I. Azhar, Rong Hu, David Goerlitz, Bhaskar V. Kallakury, Priscilla A. Furth
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-16 (2022)
Abstract Biology and transcriptomes of non-cancerous human mammary epithelial cells at risk for breast cancer development were explored following primary isolation utilizing conditional reprogramming cell technology from mastectomy tissue ipsilateral
Externí odkaz:
https://doaj.org/article/cd859bc9623041dba2c5112bad9c5e9f
Autor:
Redha I. Azhar, Priscilla A. Furth, David S. Goerlitz, Xiaogang Zhong, Bhaskar Kallakury, Weisheng Wang, Sahar J. Alothman, Islam, Archana Kishore
Publikováno v:
Cancer Prevention Research. 10:244-254
An intervention study initiated at age 4 months compared the impact of tamoxifen (25 mg), raloxifene (22.5 mg), and letrozole (2.5 mg) administered by 60-day release subcutaneous pellet on mammary preneoplasia prevalence at age 6 months in conditiona
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bc3be4888bd06e18c14d8b460144000f
https://doi.org/10.1158/1940-6207.capr-16-0268
https://doi.org/10.1158/1940-6207.capr-16-0268
Autor:
Shaunice M. Shreeves, Sara Afridi, Redha I. Azhar, Priscilla A. Furth, Weisheng Wang, Laxmi Y. Gusain, Diba Zomorrodi, Sahar J. Alothman
The field of endocrinology spans basic physiology through clinical medical application. It focuses on organs and cell types that generate hormones and their signaling through receptors in target organs. The mammary gland both produces hormones and re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a069dd9379c4186196a1bcf137c698a6
https://doi.org/10.1016/b978-0-12-801238-3.64698-6
https://doi.org/10.1016/b978-0-12-801238-3.64698-6
Autor:
Sahar J, Alothman, Weisheng, Wang, David S, Goerlitz, Md, Islam, Xiaogang, Zhong, Archana, Kishore, Redha I, Azhar, Bhaskar V, Kallakury, Priscilla A, Furth
Publikováno v:
Cancer prevention research (Philadelphia, Pa.). 10(4)
An intervention study initiated at age 4 months compared the impact of tamoxifen (25mg), raloxifene (22.5mg) and letrozole (2.5mg) administered by 60-day-release-subcutaneous-pellet on mammary preneoplasia prevalence at age 6 months in conditional ge
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::be2ed9b744c0223877187e42d01ae5bc
https://pubmed.ncbi.nlm.nih.gov/28283467
https://pubmed.ncbi.nlm.nih.gov/28283467